These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 4354120)

  • 1. A "spot-infection technique" for titration and neutralization of poliovirus.
    Baba K; Kimoto T; Morita K
    Biken J; 1973 Jun; 16(2):75-80. PubMed ID: 4354120
    [No Abstract]   [Full Text] [Related]  

  • 2. A micrometabolic inhibition test for the estimation of poliovirus neutralizing antibodies.
    Kyriazopoulou VG; Bell EJ
    Bull World Health Organ; 1972; 47(2):171-5. PubMed ID: 4345395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neutralizing antibodies in the sera of persons vaccinated with intradermal poliovirus vaccine].
    Jarzabek Z; Kańtoch M
    Przegl Epidemiol; 1984; 38(3):323-6. PubMed ID: 6098935
    [No Abstract]   [Full Text] [Related]  

  • 4. [IgM-specific neutralizing antibodies against poliovirus in cases of poliomyelitis].
    Salmerón García F
    Bol Oficina Sanit Panam; 1982 Mar; 92(3):203-7. PubMed ID: 6279126
    [No Abstract]   [Full Text] [Related]  

  • 5. Poliovirus and polio antibody assay in HEp-2 and Vero cell cultures.
    Albrecht P; Enterline JC; Boone EJ; Klutch MJ
    J Biol Stand; 1983 Apr; 11(2):91-7. PubMed ID: 6306012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated microtransfer technique for the assay of poliovirus- and mumps virus-neutralizing antibodies.
    Mayner RE; McDorman DJ; Meyer BC; Parkman PD
    Appl Microbiol; 1974 Dec; 28(6):968-71. PubMed ID: 4375437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies against poliovirus and mumps virus in Belgian recruits 1978-1979].
    Druyts-Voets E; Ruttens W
    Arch Belg Med Soc; 1981 Apr; 39(4):241-52. PubMed ID: 6275793
    [No Abstract]   [Full Text] [Related]  

  • 8. Passage of poliovirus antibodies across the placental barrier.
    Mukherjee P; Sengupta KP; Mukherjee KL
    Indian J Med Res; 1980 Jun; 71():840-6. PubMed ID: 6252101
    [No Abstract]   [Full Text] [Related]  

  • 9. Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.
    Urasawa S; Urasawa T; Kanamitsu M
    J Immunol; 1974 Aug; 113(2):537-42. PubMed ID: 4367633
    [No Abstract]   [Full Text] [Related]  

  • 10. Poliovirus antibody in milk and sera of lactating women.
    John TJ; Devarajan LV
    Indian J Med Res; 1973 Jul; 61(7):1009-12. PubMed ID: 4357090
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neutralizing antibody levels against polioviruses in persons with amyotrophic lateral sclerosis].
    Nevsímal O; Süssová J; Zikmundová L
    Cesk Neurol Neurochir; 1984 Mar; 47(2):85-9. PubMed ID: 6323039
    [No Abstract]   [Full Text] [Related]  

  • 12. [Poliomyelitis immunity status in the centro-meridional Italy].
    Ribera G; Angelillo IF; Ricciardi G; Grasso GM; Villari P
    Ann Ig; 1995; 7(6):421-9. PubMed ID: 8663971
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantification of antipoliovirus antibodies in human and simian sera.
    Arya SC; Yetts R
    Indian J Med Res; 1973 Jul; 61(7):1025-30. PubMed ID: 4357091
    [No Abstract]   [Full Text] [Related]  

  • 14. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
    Minor PD; Schild GC; Evans D; Ferguson M; Almond J
    Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardization of poliovirus neutralizing antibody tests.
    Albrecht P; van Steenis G; van Wezel AL; Salk J
    Rev Infect Dis; 1984; 6 Suppl 2():S540-4. PubMed ID: 6330853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the antigenic variation in poliovirus type 1. Selection and analysis of variant strains with monoclonal antibodies by neutralization.
    Thibodeau L; Lacroix M; Lecomte J; Fauvel M
    Dev Biol Stand; 1984; 57():157-63. PubMed ID: 6084606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
    Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
    Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged intracerebral infection with poliovirus in asymptomatic mice.
    Miller JR
    Ann Neurol; 1981 Jun; 9(6):590-6. PubMed ID: 6266333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization antigenic sites of poliovirus and peptide induction of neutralizing antibodies.
    Emini EA; Wimmer E; Jameson BA; Bonin J; Diamond D
    Ann Sclavo Collana Monogr; 1984; 1(2):139-46. PubMed ID: 6085885
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.